{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:36:52Z","timestamp":1791171412067,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.biocel.2014.02.008","type":"journal-article","created":{"date-parts":[[2014,2,20]],"date-time":"2014-02-20T22:33:07Z","timestamp":1392935587000},"page":"192-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Cystic fibrosis: Toward personalized therapies"],"prefix":"10.1016","volume":"52","author":[{"given":"Pauline T.","family":"Ikpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel J.C.","family":"Bijvelds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo R.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2014.02.008_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/clpt.2012.183","article-title":"Longitudinal cystic fibrosis care","volume":"93","author":"Antunovic","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.biocel.2014.02.008_bib0010","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1189\/jlb.0412188","article-title":"Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection","volume":"92","author":"Bonfield","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0015","first-page":"225","article-title":"Potentiator ivacaftor impedes pharmacological correction of F508del CFTR","volume":"36","author":"Cholon","year":"2013","journal-title":"Pediatr Pulmonol Suppl"},{"key":"10.1016\/j.biocel.2014.02.008_bib0020","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI115952","volume":"90","author":"Chu","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biocel.2014.02.008_bib0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1164\/rccm.201204-0785PP","article-title":"Personalized medicine in cystic fibrosis: dawning of a new era","volume":"186","author":"Clancy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.biocel.2014.02.008_bib0035","doi-asserted-by":"crossref","first-page":"e73905","DOI":"10.1371\/journal.pone.0073905","article-title":"Multicenter intestinal current measurements in rectal biopsies from CF and non-CF subjects to monitor CFTR function","volume":"8","author":"Clancy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2014.02.008_bib0040","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1073\/pnas.0400459101","article-title":"Rescuing cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by transcomplementation","volume":"101","author":"Cormet-Boyaka","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 2","key":"10.1016\/j.biocel.2014.02.008_bib0045","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S1569-1993(11)60009-X","article-title":"New clinical diagnostic procedures for cystic fibrosis in Europe","volume":"10","author":"De Boeck","year":"2011","journal-title":"J Cyst Fibros"},{"issue":"Suppl 2","key":"10.1016\/j.biocel.2014.02.008_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcf.2004.05.034","article-title":"Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers","volume":"3","author":"De Jonge","year":"2004","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.biocel.2014.02.008_bib0055","doi-asserted-by":"crossref","first-page":"a009753","DOI":"10.1101\/cshperspect.a009753","article-title":"The cystic fibrosis intestine","volume":"3","author":"De Lisle","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1183\/09059180.00008412","article-title":"Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"22","author":"Derichs","year":"2013","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.biocel.2014.02.008_bib0070","doi-asserted-by":"crossref","first-page":"35926","DOI":"10.1074\/jbc.M109.057372","article-title":"Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages","volume":"284","author":"Deriy","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0075","doi-asserted-by":"crossref","first-page":"e77314","DOI":"10.1371\/journal.pone.0077314","article-title":"Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice","volume":"8","author":"Dhooghe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2014.02.008_bib0080","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0085","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/hmg\/dds045","article-title":"An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects","volume":"21","author":"Fernandez Alanis","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2014.02.008_bib0090","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.11-2672","article-title":"Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation","volume":"142","author":"Flume","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.biocel.2014.02.008_bib0095","doi-asserted-by":"crossref","first-page":"C747","DOI":"10.1152\/ajpcell.1997.273.2.C747","article-title":"Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism","volume":"273","author":"French","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0100","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1242\/dev.096628","article-title":"Artificial three-dimensional niches deconstruct pancreas development in vitro","volume":"140","author":"Greggio","year":"2013","journal-title":"Development"},{"key":"10.1016\/j.biocel.2014.02.008_bib0105","doi-asserted-by":"crossref","first-page":"e19919","DOI":"10.1371\/journal.pone.0019919","article-title":"Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients","volume":"6","author":"Hida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2014.02.008_bib0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2217\/rme.13.39","article-title":"Lgr5(+) liver stem cells, hepatic organoids and regenerative medicine","volume":"8","author":"Huch","year":"2013","journal-title":"Regenerative Medicine"},{"key":"10.1016\/j.biocel.2014.02.008_bib0115","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1038\/emboj.2013.204","article-title":"Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5\/R-spondin axis","volume":"32","author":"Huch","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.biocel.2014.02.008_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature11826","article-title":"In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration","volume":"494","author":"Huch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2014.02.008_bib0125","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1073\/pnas.1215982110","article-title":"Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle","volume":"110","author":"Jih","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2014.02.008_bib0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3486","article-title":"TALENs: a widely applicable technology for targeted genome editing","volume":"14","author":"Joung","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0135","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s10822-010-9390-0","article-title":"Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening","volume":"24","author":"Kalid","year":"2010","journal-title":"J Comput Aided Mol Des"},{"key":"10.1016\/j.biocel.2014.02.008_bib0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.chembiol.2009.04.005","article-title":"Functional rescue of DeltaF508-CFTR by peptides designed to mimic sorting motifs","volume":"16","author":"Kim Chiaw","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1091\/mbc.e09-12-1017","article-title":"Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis","volume":"21","author":"Koulov","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.biocel.2014.02.008_bib0150","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/j.1460-2075.1992.tb05125.x","article-title":"Transfection of wild-type CFTR into cystic fibrosis lymphocytes restores chloride conductance at G1 of the cell cycle","volume":"11","author":"Krauss","year":"1992","journal-title":"EMBO J"},{"key":"10.1016\/j.biocel.2014.02.008_bib0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/biores.2012.0218","article-title":"Correction of the DeltaF508 mutation in the cystic fibrosis transmembrane conductance regulator gene by zinc-finger nuclease homology-directed repair","volume":"1","author":"Lee","year":"2012","journal-title":"Biores Open Access"},{"key":"10.1016\/j.biocel.2014.02.008_bib0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1159\/000265129","article-title":"Sildenafil acts as potentiator and corrector of CFTR but might be not suitable for the treatment of CF lung disease","volume":"29","author":"Leier","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000107531","article-title":"Cholesterol depletion and genistein as tools to promote F508delCFTR retention at the plasma membrane","volume":"20","author":"Lim","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0170","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1089\/hum.2005.16.1116","article-title":"Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells","volume":"16","author":"Liu","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.biocel.2014.02.008_bib0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ajpath.2011.10.036","article-title":"ROCK inhibitor and feeder cells induce the conditional reprogramming of epithelial cells","volume":"180","author":"Liu","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0180","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.bcp.2013.06.028","article-title":"Corrector VX-809 stabilizes the first transmembrane domain of CFTR","volume":"86","author":"Loo","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0185","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1164\/rccm.200703-344OC","article-title":"Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis","volume":"177","author":"Lubamba","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","article-title":"CFTR: folding, misfolding and correcting the DeltaF508 conformational defect","volume":"18","author":"Lukacs","year":"2012","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1261\/rna.5101903","article-title":"5\u2019 exon replacement and repair by spliceosome-mediated RNA trans-splicing","volume":"9","author":"Mansfield","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.biocel.2014.02.008_bib0200","doi-asserted-by":"crossref","first-page":"e1001593","DOI":"10.1371\/journal.pbio.1001593","article-title":"A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays","volume":"11","author":"McElroy","year":"2013","journal-title":"PLoS Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cell.2011.11.023","article-title":"Requirements for efficient correction of DeltaF508 CFTR revealed by analyses of evolved sequences","volume":"148","author":"Mendoza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2014.02.008_bib0210","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/sj.embor.7400273","article-title":"Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation","volume":"5","author":"Nissim-Rafinia","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.biocel.2014.02.008_bib0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fphar.2012.00167","article-title":"PDE5 inhibitors as potential tools in the treatment of cystic fibrosis","volume":"3","author":"Noel","year":"2012","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.biocel.2014.02.008_bib0220","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/emmm.201302699","article-title":"Discovery of novel potent DeltaF508-CFTR correctors that target the nucleotide binding domain","volume":"5","author":"Odolczyk","year":"2013","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1083\/jcb.201208083","article-title":"Fixing cystic fibrosis by correcting CFTR domain assembly","volume":"199","author":"Okiyoneda","year":"2012","journal-title":"J Cell Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0230","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores DeltaF508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0235","doi-asserted-by":"crossref","first-page":"C866","DOI":"10.1152\/ajpcell.00404.2009","article-title":"Influence of cell background on pharmacological rescue of mutant CFTR","volume":"298","author":"Pedemonte","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11130","article-title":"Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung","volume":"487","author":"Pezzulo","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2014.02.008_bib0245","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/mol.111.073056","article-title":"Cyanoquinolines with independent corrector and potentiator activities restore DeltaPhe508-cystic fibrosis transmembrane conductance regulator chloride channel function in cystic fibrosis","volume":"80","author":"Phuan","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0250","doi-asserted-by":"crossref","first-page":"L587","DOI":"10.1152\/ajplung.00465.2010","article-title":"Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators","volume":"301","author":"Pyle","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0255","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cell.2011.11.024","article-title":"Correction of both NBD1 energetics and domain interface is required to restore DeltaF508 CFTR folding and function","volume":"148","author":"Rabeh","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2014.02.008_bib0260","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1165\/rcmb.2001-0004OC","article-title":"Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis","volume":"27","author":"Ramalho","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0265","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1091\/mbc.e13-05-0240","article-title":"VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1","volume":"24","author":"Ren","year":"2013","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.biocel.2014.02.008_bib0270","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1146\/annurev.biochem.75.103004.142532","article-title":"CFTR function and prospects for therapy","volume":"77","author":"Riordan","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0275","doi-asserted-by":"crossref","first-page":"12771","DOI":"10.1073\/pnas.0906850106","article-title":"Basal cells as stem cells of the mouse trachea and human airway epithelium","volume":"106","author":"Rock","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2014.02.008_bib0280","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1378\/chest.10-2077","article-title":"Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment","volume":"139","author":"Rogan","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.biocel.2014.02.008_bib0285","first-page":"2013","article-title":"Cystic fibrosis transmembrane regulator correctors and potentiators","author":"Rowe","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0290","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biocel.2014.02.008_bib0295","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biocel.2014.02.008_bib0300","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biocel.2014.02.008_bib0305","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.biocel.2014.02.008_bib0310","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"Sermet-Gaudelus","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0315","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.2174\/13816128113199990320","article-title":"Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications","volume":"19","author":"Sohma","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.biocel.2014.02.008_bib0320","doi-asserted-by":"crossref","first-page":"e22212","DOI":"10.1371\/journal.pone.0022212","article-title":"Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis","volume":"6","author":"Sorio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biocel.2014.02.008_bib0325","doi-asserted-by":"crossref","first-page":"20035","DOI":"10.1073\/pnas.1213241109","article-title":"Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells","volume":"109","author":"Suprynowicz","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2014.02.008_bib0330","doi-asserted-by":"crossref","first-page":"L380","DOI":"10.1152\/ajplung.00129.2010","article-title":"Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function","volume":"300","author":"Tamanini","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0335","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/jcp.24101","article-title":"Lymphocyte CFTR promotes epithelial bicarbonate secretion for bacterial killing","volume":"227","author":"Tang","year":"2012","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1165\/rcmb.2012-0502OC","article-title":"Optimal complement-mediated phagocytosis of Pseudomonas aeruginosa by monocytes is cystic fibrosis transmembrane conductance regulator-dependent","volume":"49","author":"Van de Weert-van Leeuwen","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0345","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biocel.2014.02.008_bib0350","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcf.2013.06.008","article-title":"Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function","volume":"13","author":"Van Goor","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.biocel.2014.02.008_bib0355","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1074\/jbc.M609942200","article-title":"Curcumin opens cystic fibrosis transmembrane conductance regulator channels by a novel mechanism that requires neither ATP binding nor dimerization of the nucleotide-binding domains","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0360","first-page":"127","article-title":"Novel therapeutic approaches for cystic fibrosis","volume":"15","author":"Wilschanski","year":"2013","journal-title":"Discov Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09031936.00120910","article-title":"Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis","volume":"38","author":"Wilschanski","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.biocel.2014.02.008_bib0370","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1074\/jbc.M611049200","article-title":"Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach","volume":"282","author":"Wolde","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2014.02.008_bib0375","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nbt.2328","article-title":"Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein","volume":"30","author":"Wong","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0380","article-title":"Synthetic aminoglycosides efficiently suppress CFTR nonsense mutations and are enhanced by ivacaftor","author":"Xue","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.biocel.2014.02.008_bib0385","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2011.12.005","article-title":"Ivacaftor potentiation of multiple CFTR channels with gating mutations","volume":"11","author":"Yu","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.biocel.2014.02.008_bib0390","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jcf.2011.03.001","article-title":"Curcumin and genistein additively potentiate G551D-CFTR","volume":"10","author":"Yu","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.biocel.2014.02.008_bib0395","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nm.2695","article-title":"Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell","volume":"18","author":"Yui","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.biocel.2014.02.008_bib0400","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1073\/pnas.0401933101","article-title":"Reversal of cystic fibrosis phenotype in a cultured Delta508 cystic fibrosis transmembrane conductance regulator cell line by oligonucleotide insertion","volume":"101","author":"Zamecnik","year":"2004","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727251400051X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135727251400051X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:57:18Z","timestamp":1761202638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135727251400051X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":80,"alternative-id":["S135727251400051X"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2014.02.008","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis: Toward personalized therapies","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2014.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}